The Food and Drug Administration has set March 8 as the end of its emergency use authorization (EUA) for Paxlovid for adult patients, the agency has said this week. The medication is given to those considered high risk for progression to severe COVID-19, including hospitalization or death.
FDA ending emergency use authorization for Paxlovid
